Introduction to the CATIE special section.
Swartz
Marvin S
MS
Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham NC 27710, USA. swart001@mc.duke.edu
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D002986:Clinical Trials as Topic; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use; D003071:Cognition / Q000187:drug effects; D006291:Health Policy; D006801:Humans; D010546:Perphenazine / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D010546:Perphenazine; D003024:Clozapine